Published 5 March 2009, doi:10.1136/bmj.b800
Cite this as: BMJ 2009;338:b800

Editorials

Tight control of blood glucose in long standing type 2 diabetes

Reducing glycated haemoglobin below 7% is not supported by evidence and may even be harmful

The first 150 words of the full text of this article appear below.

During the past year, three important studies have provided evidence that tighter glycaemic control (to <7% glycated haemoglobin) in older adults with type 2 diabetes does not provide substantial benefit and may increase the risk of adverse outcomes. These findings, which some experts and policy makers found surprising, should lead to the re-evaluation of recommendations about what constitutes high quality care for these patients.

The management of type 2 diabetes in the United Kingdom takes place largely in primary care and is strongly influenced by the requirements of the quality and outcomes framework (QOF)—an annual reward and incentive programme, which although voluntary provides a substantial proportion of general practitioners’ income. From April 2009, general practitioners in the UK will need to reduce glycated haemoglobin in half of their patients with type 2 diabetes to below 7% to earn the same amount that they are currently paid for achieving a target . . . [Full text of this article]

Richard Lehman, general practitioner1, Harlan M Krumholz, Harold H Hines Junior professor of medicine and epidemiology and public health2

1 Hightown Surgery, Banbury OX16 9DB, 2 Section of Cardiovascular Medicine and Robert Wood Johnson Clinical Scholars Program, Department of Medicine, Section of Health Policy and Administration, School of Public Health, Yale University School of Medicine, PO Box 208088, New Haven, CT 06520-8088, USA

richard.lehman@nhs.net


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

QOF and whistleblowers
Jane Smith
BMJ 2009 338: b2263. [Extract] [Full Text]

New QOF glycaemia targets are achievable and evidence based
Simon Griffin and Jonathan Graffy
BMJ 2009 338: b1915. [Extract] [Full Text]

Time to abolish QOF
Ted Willis
BMJ 2009 338: b1916. [Extract] [Full Text]

When is a target an inducement?
Harry Hall
BMJ 2009 338: b1918. [Extract] [Full Text]

Education with an angle
Jane Smith
BMJ 2009 338: b1548. [Extract] [Full Text]

This article has been cited by other articles:

  • Griffin, S., Graffy, J. (2009). New QOF glycaemia targets are achievable and evidence based. BMJ 338: b1915-b1915 [Full text]  
  • Willis, T. (2009). Time to abolish QOF. BMJ 338: b1916-b1916 [Full text]  
  • Hall, H. (2009). When is a target an inducement?. BMJ 338: b1918-b1918 [Full text]  

Rapid Responses:

Read all Rapid Responses

Aim for good evidence based targets
Rupert A Gude
bmj.com, 11 Mar 2009 [Full text]
Hypoglycemia in the patients with long lasting T2DM
Gauranga C. Dhar
bmj.com, 11 Mar 2009 [Full text]
The individual patient should decide what their target hbaic should be.
Katharine M Morrison
bmj.com, 12 Mar 2009 [Full text]
Hidden dangers in rebound hyperglycaemia.
Richard G Fiddian-Green
bmj.com, 12 Mar 2009 [Full text]
Whose idea was this ?
Harry Hall
bmj.com, 12 Mar 2009 [Full text]
Re: Hidden dangers in rebound hyperglycaemia.
Gauranga C. Dhar
bmj.com, 13 Mar 2009 [Full text]
In defence of QOF targets
Richard A Brice
bmj.com, 13 Mar 2009 [Full text]
Sensible, evidence-based QoF targets
Peter D Burrill
bmj.com, 17 Mar 2009 [Full text]
New QOF glycaemia targets are achievable and based on a balanced review of available evidence
Simon J Griffin, et al.
bmj.com, 26 Mar 2009 [Full text]
Glycaemic targets in diabetes: It's time to put patients first.
Jyothis George, et al.
bmj.com, 19 Apr 2009 [Full text]
Ethics of QOF
Edward TJ Chandy
bmj.com, 19 Apr 2009 [Full text]
Re: Ethics of QOF
L Sam Lewis
bmj.com, 19 Apr 2009 [Full text]
No competing interests - who are you kidding
ted willis
bmj.com, 20 Apr 2009 [Full text]
Re: Glycaemic targets in diabetes: It's time to put patients first.
Angus H N Whitfield
bmj.com, 20 Apr 2009 [Full text]
Re: Re: Ethics of QOF
Mark Struthers
bmj.com, 20 Apr 2009 [Full text]
Re: Re: Re: Ethics of QOF
L Sam Lewis
bmj.com, 21 Apr 2009 [Full text]
Re: Re: Re: Re: Ethics of QOF
Edward TJ Chandy
bmj.com, 21 Apr 2009 [Full text]
Re: Re: Re: Re: Re: Ethics of QOF
L Sam Lewis
bmj.com, 22 Apr 2009 [Full text]
Re: Re: Re: Re: Re: Ethics of QOF
Harry Hall
bmj.com, 22 Apr 2009 [Full text]
Re: Re: Re: Re: Re: Re: Ethics of QOF
Tracy Monk
bmj.com, 23 Apr 2009 [Full text]
Is hyperinsulinemia the culprit for worse results orf aggressive glucose control?
Wenyi Yang
bmj.com, 23 Apr 2009 [Full text]
Re: Re: Re: Re: Re: Re: Re: Ethics of QOF
Jonathan P Richards
bmj.com, 25 Apr 2009 [Full text]
Time for Patient-driven goals?
Mark E McConnell
bmj.com, 1 May 2009 [Full text]
Definitions of 'tight control' are not consistent.
David K Lewis
bmj.com, 12 May 2009 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ